8 is Enough. Accelerating HCV Elimination in a Post-Pandemic World

Overview

This webinar features presentations by leading Australian experts on Hepatitis C virus (HCV) who will discuss HCV elimination in Australia, including strategies to simplify the HCV care cascade, benefits of HCV cure*, and the latest MAVIRET (glecaprevir/pibrentasvir) data available for treatment naïve compensated cirrhotic HCV patients.
*Cure defined as HCV RNA below the lower limit of detection at 12 weeks post end-of-treatment (SVR12)